Decreased serum bilirubin is associated with arterial stiffness in men

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 23, Issue 4, 2013, Pages 375-381

  Li, Y ^a   Meng, S Y ^a   Meng, C C ^a   Yu, W G ^a   Wang, R T ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidant; Arterial stiffness; Arteriosclerosis; Brachial ankle pulse wave velocity; Total bilirubin

Indexed keywords

BILIRUBIN; BIOLOGICAL MARKER;

ADULT; ANALYSIS OF VARIANCE; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CHI SQUARE DISTRIBUTION; CHINA; CROSS-SECTIONAL STUDY; DOWN REGULATION; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PULSE WAVE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL;

ADULT; ANALYSIS OF VARIANCE; ANKLE BRACHIAL INDEX; BILIRUBIN; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CHINA; CROSS-SECTIONAL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULSE WAVE ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; VASCULAR STIFFNESS;

EID: 84875082749     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2011.09.004     Document Type: Article

References (39)

1. O'Rourke M.F., Franklin S.S. Arterial stiffness: reflections on the arterial pulse. Eur Heart J 2006, 27:2497-2498.
2. Yamashina A., Tomiyama H., Takeda K., Tsuda H., Arai T., Hirose K., et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002, 25:359-364.
3. Satoh H., Kishi R., Tsutsui H. Metabolic syndrome is a significant and independent risk factor for increased arterial stiffness in Japanese subjects. Hypertens Res 2009, 32:1067-1071.
4. Tomiyama H., Tanaka H., Hashimoto H., Matsumoto C., Odaira M., Yamada J., et al. Arterial stiffness and declines in individuals with normal renal function/early chronic kidney disease. Atherosclerosis 2010, 212:345-350.
5. Turin T.C., Kita Y., Rumana N., Takashima N., Kadota A., Matsui K., et al. Brachial-ankle pulse wave velocity predicts all-cause mortality in the general population: findings from the Takashima study. Japan Hypertens Res 2010, 33:922-925.
6. Xu L., Jiang C.Q., Lam T.H., Yue X.J., Cheng K.K., Liu B., et al. Brachial-ankle pulse wave velocity and cardiovascular risk factors in the non-diabetic and newly diagnosed diabetic Chinese: Guangzhou Biobank Cohort Study-CVD. Diabetes Metab Res Rev 2010, 26:133-139.
7. Franchini M., Targher G., Lippi G. Serum bilirubin levels and cardiovascular disease risk: a Janus Bifrons. Adv Clin Chem 2010, 50:47-63.
8. Vitek L., Jirsa M., Brodanova M., Kalab M., Marecek Z., Danzig V., et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 2002, 160:449-456.
9. Erdogan D., Gullu H., Yildirim E., Tok D., Kirbas I., Ciftci O., et al. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis 2006, 184:431-437.
10. Vitek L., Novotny L., Sperl M., Holaj R., Spacil J. The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis. Cerebrovasc Dis 2006, 21:408-414.
11. Perlstein T.S., Pande R.L., Beckman J.A., Creager M.A. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol 2008, 28:166-172.
12. Novotny L., Vitek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood) 2003, 228:568-571.
13. Kimm H., Yun J.E., Jo J., Jee S.H. Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke 2009, 40:3422-3427.
14. Allen L.A., Felker G.M., Pocock S., McMurray J.J., Pfeffer M.A., Swedberg K., et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in HEART Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail 2009, 11:170-177.
15. Takeda Y., Takeda Y., Tomimoto S., Tani T., Narita H., Kimura G. Bilirubin as a prognostic marker in patients with pulmonary arterial hypertension. BMC Pulm Med 2010, 10:22.
16. Wang R.T., Li Y., Zhu X.Y., Zhang Y.N. Increased mean platelet volume is associated with arterial stiffness. Platelets 2011.
17. Molvarec A., Rigo J., Lazar L., Balogh K., Mako V., Cervenak L., et al. Increased serum heat-shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia. Cell Stress Chaperones 2009, 14:151-159.
18. Bulmer A.C., Blanchfield J.T., Toth I., Fassett R.G., Coombes J.S. Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. Atherosclerosis 2008, 199:390-396.
19. Basiglio C.L., Arriaga S.M., Pelusa F., Almara A.M., Kapitulnik J., Mottino A.D. Complement activation and disease: protective effects of hyperbilirubinaemia. Clin Sci (Lond) 2010, 118:99-113.
20. Arriaga S.M., Basiglio C.L., Mottino A.D., Almara A.M. Unconjugated bilirubin inhibits C1 esterase activity. Clin Biochem 2009, 42:919-921.
21. Kinderlerer A.R., Pombo G.I., Hamdulay S.S., Ali F., Steinberg R., Silva G., et al. Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin. Blood 2009, 113:1598-1607.
22. Bellien J., Favre J., Iacob M., Gao J., Thuillez C., Richard V., et al. Arterial stiffness is regulated by nitric oxide and endothelium-derived hyperpolarizing factor during changes in blood flow in humans. Hypertension 2010, 55:674-680.
23. Pae H.O., Son Y., Kim N.H., Jeong H.J., Chang K.C., Chung H.T. Role of heme oxygenase in preserving vascular bioactive NO. Nitric Oxide 2010, 23:251-257.
24. Galis Z.S., Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002, 90:251-262.
25. Chung A.W., Yang H.H., Kim J.M., Sigrist M.K., Chum E., Gourlay W.A., et al. Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease. Circulation 2009, 120:792-801.
26. Liu P.L., Tsai J.R., Charles A.L., Hwang J.J., Chou S.H., Ping Y.H., et al. Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases. Mol Nutr Food Res 2010, 54(Suppl. 2):S196-S204.
27. Mazzone G.L., Rigato I., Ostrow J.D., Bossi F., Bortoluzzi A., Sukowati C.H., et al. Bilirubin inhibits the TNFalpha-related induction of three endothelial adhesion molecules. Biochem Biophys Res Commun 2009, 386:338-344.
28. Keshavan P., Deem T.L., Schwemberger S.J., Babcock G.F., Cook-Mills J.M., Zucker S.D. Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. J Immunol 2005, 174:3709-3718.
29. Ochi M., Kohara K., Tabara Y., Kido T., Uetani E., Ochi N., et al. Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men. Atherosclerosis 2010, 212:327-332.
30. Yamamoto K., Kawano H., Gando Y., Lemitsu M., Murakami H., Sanada K., et al. Poor trunk flexibility is associated with arterial stiffening. Am J Physiol Heart Circ Physiol 2009, 297:H1314-H1318.
31. Okamoto T., Masuhara M., Ikuta K. Combined aerobic and resistance training and vascular function: effect of aerobic exercise before and after resistance training. J Appl Physiol 2007, 103:1655-1661.
32. Kadakol A., Ghosh S.S., Sappal B.S., Sharma G., Chowdhury J.R., Chowdhury N.R. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat 2000, 16:297-306.
33. Hamden K., Jaouadi B., Carreau S., Aouidet A., Elfeki A. Therapeutic effects of soy isoflavones on alpha-amylase activity, insulin deficiency, liver-kidney function and metabolic disorders in diabetic rats. Nat Prod Res 2011, 25:244-255.
34. Zhou J., Tracy T.S., Remmel R.P. Correlation between bilirubin glucuronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyltransferase 1A1 substrates/inhibitors. Drug Metab Dispos 2011, 39:322-329.
35. Hayashi K., Miyachi M., Seno N., Takahashi K., Yamazaki K., Sugawara J., et al. Variations in carotid arterial compliance during the menstrual cycle in young women. Exp Physiol 2006, 91:465-472.
36. Miura S., Tanaka E., Mori A., Toya M., Takahashi K., Nakahara K., et al. Hormone replacement therapy improves arterial stiffness in normotensive postmenopausal women. Maturitas 2003, 45:293-298.
37. Perrot-Applanat M., Groyer-Picard M.T., Garcia E., Lorenzo F., Milgrom E. Immunocytochemical demonstration of estrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans. Endocrinology 1988, 123:1511-1519.
38. Fujimoto R., Morimoto I., Morita E., Sugimoto H., Ito Y., Eto S. Androgen receptors, 5 alpha-reductase activity and androgen-dependent proliferation of vascular smooth muscle cells. J Steroid Biochem Mol Biol 1994, 50:169-174.
39. Clementi M., Di G.E., Fabris L., Forabosco P., Strazzabosco M., Tenconi R., et al. Inheritance of hyperbilirubinemia: evidence for a major autosomal recessive gene. Dig Liver Dis 2007, 39:351-355.